New guidance on use of infliximab in ulcerative colitis

NICE has issued guidance on the use of infliximab for the treatment of acute exacerbations of ulcerative colitis.

The guidance states that infliximab should only be used in people with acute, severely active ulcerative colitis if treatment with ciclosporin is contraindicated or clinically inappropriate, or if they are taking part in a clinical trial.

A summary of the new guidance is available at www.mims.co.uk.  To read the full guidance visit the NICE website.

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

Women taking valproate still unaware of pregnancy risks, survey finds

Women taking valproate still unaware of pregnancy risks, survey finds

One in ten women currently taking valproate are unaware...

Live updates: Coronavirus (COVID-19) in the UK

Live updates: Coronavirus (COVID-19) in the UK

Use our timeline to follow the latest coronavirus developments...

Experts urge vitamin D supplementation and call for research into possible COVID-19 benefits
Drug shortages - live tracker

Drug shortages - live tracker

Use our constantly updated shortages tracker to check...